Discover Global lung cancer therapeutics market outlook to 2020
Pipe and cigar smoking are some other causes of lung cancer. Lung cancer is treated through surgery, chemotherapy, radiation therapy, immunotherapy and vaccine therapy. The primary lung carcinomas originate from epithelial cells. Non-small cell lung ...
WhaTech - Wed, 03 Dec 2014 06:03

US FDA approves Lilly' Cyramza in combo with docetaxel to treat patients with ...
Specifically, Cyramza is now also indicated in combination with docetaxel, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with disease progression on or after platinum-based chemotherapy. Patients with epidermal growth ... - Wed, 17 Dec 2014 20:41

Cyramza gets FDA green light in lung cancer
Eli Lilly bagged an important new indication for its cancer therapy Cyramza after the FDA approved it as a treatment for advanced non-small cell lung cancer (NSCLC). Cyramza (ramucirumab) - a VEGFR2 antagonist that works by blocking the blood supply ...
PMLiVE - Mon, 15 Dec 2014 03:39

Ramucirumab-Docetaxel Approved for Advanced NSCLC
Cancer Network - Fri, 12 Dec 2014 11:52

Lilly's CYRAMZA® (ramucirumab) Receives Third FDA Approval
SYS-CON Media (press release) - Tue, 16 Dec 2014 11:41

Checkpoint parley
Herbst et al. found that treatment with the PD1 ligand 1 (PDL1)-specific monoclonal antibody MPDL3280A reduced metastatic lesions in patients with advanced incurable cancers, including non-small-cell lung cancer, melanoma and renal cell carcinoma; ... - Wed, 10 Dec 2014 23:59

Anti-PD-L1 Drug Shows Promise in Bladder Cancer
An interesting hallmark of UBC is a high rate of somatic mutations, which could aid in an immune response that would recognize tumor cells as foreign; expression of PD-L1, though, limits that response. Thus, the anti-PD-L1 drug was considered as an ...
Cancer Network - Wed, 10 Dec 2014 04:16

NICE proposes to recommend a new treatment for some people with advanced ...
In advanced disease, the cancer has spread inside the kidney, and may or may not have spread to nearby lymph glands. NICE has previously recommended two drugs for advanced renal cell carcinoma, sunitinib and pazopanib- both as first-line treatments.
NICE - Tue, 16 Dec 2014 00:26

New advanced kidney cancer treatment - Tue, 16 Dec 2014 05:41

Carboplatin and paclitaxel show promise for advanced thymic carcinoma
A multicentre, phase II study of carboplatin and paclitaxel (CbP) in chemotherapy-naïve patients with advanced thymic carcinoma has shown that the treatment has promising efficacy compared with standard anthracycline-based chemotherapy. Thymic ... - Wed, 10 Dec 2014 14:16

Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug ...
Polaris Group is also investigating ADI-PEG 20 as a treatment for other cancers, such as leukemia, lymphoma, melanoma, mesothelioma, non-small cell lung cancers, sarcoma, breast, ovarian, and pancreatic cancer. In addition to the ADI-PEG 20 program, ...
Digital Journal - Thu, 18 Dec 2014 10:22

<-   1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014